{"id":"NCT01147848","sponsor":"GlaxoSmithKline","briefTitle":"HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and Adolescents","officialTitle":"A Randomised, Double-blind, Double-dummy, Parallel-group Multicentre Study to Assess Efficacy and Safety of Fluticasone Furoate/GW642444 Inhalation Powder and Fluticasone Propionate/Salmeterol Inhalation Powder in the Treatment of Persistent Asthma in Adults and Adolescents","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-06","primaryCompletion":"2011-07","completion":"2011-07","firstPosted":"2010-06-22","resultsPosted":"2013-09-05","lastUpdate":"2017-01-18"},"enrollment":810,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"Fluticasone furoate/Vilanterol Inhalation Powder","otherNames":[]},{"type":"DRUG","name":"Fluticasone propionate/salmeterol Inhalation Powder","otherNames":[]},{"type":"DRUG","name":"Placebo (1)","otherNames":[]},{"type":"DRUG","name":"Placebo (2)","otherNames":[]}],"arms":[{"label":"Fluticasone furoate/Vilanterol (GW642444)","type":"EXPERIMENTAL"},{"label":"Fluticasone propionate/salmeterol","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of the study is to compare the efficacy and safety of fluticasone furoate/vilanterol (GW642444) inhalation powder administered once daily with fluticasone propionate/salmeterol administered twice daily in adolescent and adult subjects 12 years of age and older with persistent bronchial asthma over a 24-week period.","primaryOutcome":{"measure":"Change From Baseline in Weighted-mean 24 Hour Serial FEV1 on Day 168/Week 24","timeFrame":"Baseline and Day 168/Week 24","effectByArm":[{"arm":"Fluticasone Furoate/Vilanterol 100/25 µg OD","deltaMin":0.341,"sd":0.0184},{"arm":"Fluticasone Propionate/Salmeterol 250/50 µg BID","deltaMin":0.377,"sd":0.0185}],"pValues":[{"comp":"OG000 vs OG001","p":"0.162"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":8},"locations":{"siteCount":63,"countries":["United States","Argentina","Chile","Netherlands","Philippines","South Korea"]},"refs":{"pmids":["36472162","23846316"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":403},"commonTop":["Nasopharyngitis","Headache","Upper respiratory tract infection","Cough","Pyrexia"]}}